PA
Panacea Biotec Limited
PANACEABIO.BO · BSE
₹349.15 -2.44% (-₹8.75)
1M -5.57%
Market Cap ₹22.1B
P/E Ratio -
Div. Yield -
ROE 0.86%
Bulios Fair Price
₹196.86
43.6% downside
Current Price
₹349.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PANACEABIO.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
28 /100
Expensive P/S 3.28x
P/B 2.64x
EV/EBITDA 191.92x
Growth
63 /100
Stable Book val. growth 0.35%
Rev. growth 11.87%
FCF growth N/A
Profitability
12 /100
Weak FCF margin 3.88%
Op. margin 4.52%
Gross margin 31.51%
Quality
7 /100
Poor Asset turnover 0.53x
ROA 0.56%
ROIC 2.86%
Debt
76 /100
Low Net debt/EBITDA -3.61x
Int. coverage -3.34x
Debt/Equity 0.03x
Stability
28 /100
Unstable Profitable years 0
EPS volatility 397.91%
Beta 0.14x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PANACEABIO.BO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rajesh Jain
Employees
2,102
Headquarters
New Delhi